All In Biotech

Drug Trial Radar · NCT06723392

Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries

Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries: A Randomized Controlled Trial of the Global Network for Women's and Children's Health Research

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,134 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,134

Planned (sponsor's estimate)

Start

Dec 8, 2025

Primary completion

Sep 2028

Study completion Nov 2028

Sponsor

Sponsor type
Research network
Collaborators
RTI International; University of Virginia; University of Alabama at Birmingham; Thomas Jefferson University; Columbia University; Boston University; University of Colorado, Denver; University of North Carolina, Chapel Hill; International Centre for Diarrhoeal Disease Research, Bangladesh; Kinshasa School of Public Health; Institute of Nutrition of Central America and Panama; Lata Medical Research Foundation, Nagpur; Aga Khan University; University Teaching Hospital, Lusaka, Zambia; KLE Academy of Higher Education and Research (Deemed- to- be-University), Jawaharlal Nehru Medical College (JNMC), Belagavi, India
First posted
Dec 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 49 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study, Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries (ABLE), is designed as a 2-arm randomized controlled trial (RCT) focused on pregnant individuals and newborn infants. A positive outcome of this study will contribute to global progress toward WHO Sustainable Development Goal Target 3.2 \[End preventable deaths of newborns and children under 5 years of age\] by examining the potential impact of this practice to reduce the incidence of SVN/SB and the lifelong health consequences associated with SVNs. In addition, the study will further explore the role and potential benefits of antibiotic treatment of AB in the pregnant individual. In total, 1,134 eligible participants, or approximately 162 per research site, will be randomized in the trial by the research teams in each of the seven international sites that, together with their United States of America (US) partners, participate in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's (NICHD's) Global Network for Women's and Children's Health Research (GN).

Conditions

  • Preterm Birth
  • Small for Gestational Age (SGA)
  • Stillbirth
  • Bacteriuria (Asymptomatic) in Pregnancy

Interventions

  • Oral nitrofurantoin monohydrate/macrocrystalsDrug

    7-day course of oral nitrofurantoin monohydrate/macrocrystals 100 mg twice daily (total of 14 doses)

  • PlaceboOther

    7-day course of oral placebo 100 mg twice daily (total of 14 doses)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of small vulnerable newborn (SVN) or stillbirth (SB)Time frame: From Pregnancy until 42 days postpartum

Locations

7 sites in 6 countries. Site status is shown where the registry gives one.

  • Icddr,B

    Dhaka, Bangladesh, Bangladesh · Recruiting

  • Kinshasa School of Public Health

    Kinshasa, DRC, Democratic Republic of the Congo · Not yet recruiting

  • Institue for Nutrition of Central America and Panama (INCAP)

    Guatemala City, Departamento de Guatemala, Guatemala · Not yet recruiting

  • KLE Academy of Higher Education and Research

    Belagavi, Karnataka, India · Recruiting

  • Lata Medical Research Foundation

    Nagpur, Maharashtra, India · Not yet recruiting

  • Aga Khan University

    Karachi, Pakistan, Pakistan · Not yet recruiting

  • University Teaching Hospital

    Lusaka, Zambia, Zambia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.